NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
MondayMar 13, 2017 6:30 pm

Extreme Networks, Inc. (NASDAQ: EXTR) Starts Presentation at 29th Annual ROTH Conference

Extreme Networks (NASDAQ: EXTR) delivers software-driven networking solutions that help IT departments everywhere deliver the ultimate business outcome: stronger connections with customers, partners and employees. Wired to wireless, desktop to data center, on premise or through the cloud, the company provides solutions in over 80 countries, delivering 100% insourced call-in technical support to organizations large and small, including some of the world's leading names in business, hospitality, retail, transportation and logistics, education, government, healthcare and manufacturing. Founded in 1996, Extreme is headquartered in San Jose, California. For more information, visit the company’s website at www.extremenetworks.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

MondayMar 13, 2017 6:30 pm

Diversified Restaurant Holdings, Inc. (NASDAQ: SAUC) Starts Presentation at 29th Annual ROTH Conference

Diversified Restaurant Holdings (NASDAQ: SAUC) operates as a restaurant company in the United States. The company operates Buffalo Wild Wings Grill & Bar franchised restaurants, which primarily offer chicken wings, boneless wings, and other items, including chicken tenders, flatbreads, popcorn shrimps, specialty hamburgers and sandwiches, wraps, soft tacos, appetizers and salads. As of June 21, 2016, Diversified Restaurant Holdings operated 64 Buffalo Wild Wings Grill & Bar franchised restaurants in Florida, Illinois, Indiana, Michigan and Missouri. For more information, visit the company’s website at www.diversifiedrestaurantholdings.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Continue Reading

MondayMar 13, 2017 6:30 pm

Willdan Group, Inc. (NASDAQ: WLDN) Starts Presentation at 29th Annual Roth Conference

Willdan Group (NASDAQ: WLDN) provides professional technical and consulting services to utilities, private industry, and public agencies at various levels of government primarily in the Unites States. The Energy Efficiency Services segment offers comprehensive surveys, program design, master planning, benchmarking analysis. The Engineering Services segment provides a range of engineering related services, such as building and safety, city engineering, code enforcement, development plan review and inspection, disaster recovery, environmental consulting and remediation. Willdan’s Public Finance Services segment offers district administration, financial consulting, and federal compliance services. The Homeland Security Services segment provides emergency preparedness planning, training, and exercises. The company…

Continue Reading

MondayMar 13, 2017 6:30 pm

American Vanguard Corp. (NYSE: AVD) Starts Presentation at 29th Annual ROTH Conference

American Vanguard (NYSE: AVD) is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The company employs a strategy of acquiring or licensing both new and well-established product lines that serve numerous high valued market niches. New product development and international expansion also provide an additional stimulus for growth. The company is included on the Russell 2000® & Russell 3000® Indexes and the Standard & Poors 600 Index. For more information, visit the company’s website at www.american-vanguard.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

MondayMar 13, 2017 6:30 pm

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) Starts Presentation at 29th Annual Roth Conference

Titan Pharmaceuticals (NASDAQ: TTNP) is a specialty pharmaceutical company that develops proprietary therapeutics for the treatment of serious medical disorders in the United States. It develops products based on ProNeura, a proprietary long-term drug delivery technology that focuses primarily on treatments for chronic diseases, such as Parkinson’s disease. The company offers Probuphine, a product candidate for long term maintenance treatment of opioid dependence. It is also developing ProNeura-Ropinirole, an implant to provide long-term delivery of ropinirole, a dopamine agonist for the treatment of Parkinson’s disease; ProNeura-Triiodothyronine, and an implant to provide long-term delivery of triiodothyronine for the treatment of hypothyroidism.…

Continue Reading

MondayMar 13, 2017 6:30 pm

Flex Pharma, Inc. (NASDAQ: FLKS) Starts Presentation at 29th Annual ROTH Conference

Flex Pharma (NASDAQ: FLKS) is a biotechnology company focused on developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D. For more information, visit the company’s website at www.flex-pharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of…

Continue Reading

MondayMar 13, 2017 6:30 pm

Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Starts Presentation at 29th Annual ROTH Conference

Actinium Pharmaceuticals (NYSE: ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapies for the treatment of advanced cancers. The company’s radio-immunotherapy product candidates are based on the combination of the cancer targeting precision of monoclonal antibodies (mAb) that seek out specific types of cells combined with the cytotoxic killing power of radioisotopes that unleash their energy once they have reached their target. For more information, visit the company’s website at www.actiniumpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…

Continue Reading

MondayMar 13, 2017 6:00 pm

Iconix Brand Group, Inc. (NASDAQ: ICON) Starts Presentation at 29th Annual ROTH Conference

Iconix Brand Group (NASDAQ: ICON) owns, licenses and markets a growing portfolio of consumer brands including: Candie’s®, Bongo®, Joe Boxer®, Rampage®, Mudd®, Mossimo®, London Fog®, Ocean Pacific®, Danskin®, Rocawear®, Cannon®, Royal Velvet®, Fieldcrest®, and many others. Additionally, the company owns interests in brands such as Material Girl®, Peanuts®, Ed Hardy® and Truth or Dare®. The company licenses its brands to a network of leading retailers and manufacturers that touch every major segment of retail distribution from the luxury market to the mass market in both the U.S. and worldwide. Through its in-house business development, merchandising, advertising and public relations departments, Iconix…

Continue Reading

MondayMar 13, 2017 6:00 pm

NantKwest (NASDAQ: NK) Starts Presentation at 29th Annual ROTH Conference

NantKwest (NASDAQ: NK) is a biotechnology company that engages in the development of immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in phase II clinical trials for the treatment of polyoma virus induced merkel cell carcinoma. It is also developing high-affinity natural killer product candidates primarily for the treatment of solid tumors, breast cancer, multiple myeloma, lymphoma, and…

Continue Reading

MondayMar 13, 2017 6:00 pm

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Starts Presentation at 29th Annual ROTH Conference

Madrigal Pharmaceuticals (NASDAQ: MDGL) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapies for the treatment of cardiovascular, metabolic, and liver diseases. The company’s lead candidate is MGL-3196, which has completed Phase I single and multiple dose trials, an orally administered and small-molecule liver-directed selective thyroid hormone receptor-beta agonist for use in the treatment of nonalcoholic steatohepatitis (NASH), and heterozygous and homozygous familial hypercholesterolemia (FH) to lower LDL cholesterol, triglyceride levels, and Lp(a). For more information, visit the company’s website at www.madrigalpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright 2015 - 2025. NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers